•
Dec 31, 2014

EyePoint Pharmaceuticals Q2 2015 Earnings Report

Total Revenue
$521K
Previous year: $590K
-11.7%
EPS
-$1.4
Previous year: -$1.3
+7.7%
Gross Profit
-$2.25M
Previous year: -$1.9M
+18.1%
Cash and Equivalents
$29.8M
Previous year: $15.2M
+95.5%
Total Assets
$40.2M
Previous year: $20.8M
+93.0%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals